[
  {
    "headline": "top biotech halozyme undercut breakout bad medicare news",
    "text": "halozyme therapeutic tumble tuesday new medicare approach negotiation drug use additive product"
  },
  {
    "headline": "breakneck speed cancer breakthrough oncologist feel left behind big pharma chime",
    "text": "community oncologist good keep new treatment pace cancer approval drugmaker need team doctor front line"
  },
  {
    "headline": "p dow pharma boomerang drug pricing order bark little bite",
    "text": "pharmaceutical boomerang monday trump sign executive order tie drug u.s international tag"
  },
  {
    "headline": "histosonic secure first insurance coverage histotripsy system",
    "text": "michigan first us state offer reimbursement histonic fda approve edison histotripsy system"
  },
  {
    "headline": "trump expect sign order slash drug",
    "text": "president trump expect sign executive order intend cut prescription drug order match drug overseas yahoo senior health reporter anjalee khemlani outline many step government agency involve investigate carry act watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "mag 7 rally airline pharmaceutical trend ticker",
    "text": "magnificent seven make nvidia nvda alphabet goog googl tesla tsla microsoft msft amazon amzn meta meta apple aapl rally us china agree lower tariff 90 day period airline like american airlines aal delta dal united airlines ual also gain trade deal pharmacy include eli lilly lly johnson johnson jnj merck mrk move downside us president trump say cut drug 50 watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "us china trade truce april cpi drug 3 thing",
    "text": "us future es f nq f ym f surge monday morning china official agree significant cut country respective tariff 90 day cool period april consumer cpi due tomorrow report month month trend inflation president trump vow cut prescription drug much 80 turn pharmaceutical see across board pullback pre watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "pharma fall pre bell follow plan trump reduce prescription drug",
    "text": "pfizer pfe astrazeneca azn johnson johnson jnj drug company fall mond"
  },
  {
    "headline": "j j report new datum phase iii trial icotrokinra plaque psoriasis",
    "text": "primary endpoint meet 57 subject treat therapy achieve clear almost clear skin"
  },
  {
    "headline": "johnson johnson jnj good income invest",
    "text": "recently publish list good income invest article go take look johnson johnson nyse jnj stand good income amid concern trade restriction weakening economy seek stability dividend pay traditional defensive"
  },
  {
    "headline": "johnson johnson nyse jnj announce positive trial result amid legal setback",
    "text": "johnson johnson nyse jnj recently announce promising phase 3 result icotrokinra new investigational treatment psoriasis face legal challenge jury award $ 3 million verdict link baby powder use development coincide 3.77 rise company past month movement reflect broad trend dow jones relatively flat amid ongoing u.s.-china tariff discussion johnson johnson positive"
  },
  {
    "headline": "j j oral psoriasis drug help patient achieve clear skin late stage study",
    "text": "drugmaker work convenient treatment option injectable psoriasis drug stelara gain $ 10 billion sale last year face stiff competition cheap rival j j say last month expect drug icotrokinra generate sale $ 700 million 2028 btig analyst julian harrison expect icotrokinra complement rather disrupt leader include j j tremfya abbvie skyrizi"
  },
  {
    "headline": "icotrokinra result show significant skin clearance patient difficult treat scalp genital psoriasis",
    "text": "johnson johnson nyse jnj today announce new datum phase 3 iconic totala study investigate icotrokinra jnj-2113 first class investigational target oral peptide selectively block il-23 receptor study evaluate adult adolescent 12 year age old body surface area low 1 least moderate plaque psoriasis pso affect high impact skin site"
  },
  {
    "headline": "johnson johnson jnj good medical device buy",
    "text": "recently publish list 11 good medical device buy article go take look johnson johnson nyse jnj stand good medical device buy trump tariff divide medical community april 16 cnbc report trump tariff"
  },
  {
    "headline": "zymeworks inc zyme q1 2025 earning call highlight revenue surge strategic partnership",
    "text": "zymeworks inc zyme report significant revenue increase strong cash position navigate rise expense strategic uncertainty"
  },
  {
    "headline": "look pharma etfs strong q1 earning",
    "text": "many pharma bigwig report solid result beat earning revenue"
  },
  {
    "headline": "listerine tylenol maker kenvue top estimate lift net sale outlook",
    "text": "kenvue rise early thursday maker band aid tylenol listerine report first quarter result well analyst estimate"
  },
  {
    "headline": "johnson johnson expand effort champion nursing workforce globally",
    "text": "new brunswick n.j may 08 2025 -johnson johnson today announce expansion effort champion nursing workforce improve access quality care community around world effort part j j carecommunity new social impact platform focus resource expertise j j j j foundation support nurse every step career journey strengthen health system worldwide expansion aim help address global shortfall nu"
  },
  {
    "headline": "fda expand surprise inspection foreign drug food facility target double standard overseas manufacturing oversight",
    "text": "u.s food drug administration fda announce intent expand use unannounced inspection foreign manufacturing facility produce food essential medicine medical product intend american consumer patient change build upon agency office inspection investigation foreign unannounced inspection pilot program india china aim ensure foreign company receive level regulatory oversight"
  },
  {
    "headline": "johnson johnson jnj good dow",
    "text": "recently publish list good bad dow article go take look johnson johnson nyse jnj stand dow dow jones industrial average benchmark top 30 company us represent strength"
  },
  {
    "headline": "top biotech halozyme undercut breakout bad medicare news",
    "text": "halozyme therapeutic tumble tuesday new medicare approach negotiation drug use additive product"
  },
  {
    "headline": "breakneck speed cancer breakthrough oncologist feel left behind big pharma chime",
    "text": "community oncologist good keep new treatment pace cancer approval drugmaker need team doctor front line"
  },
  {
    "headline": "p dow pharma boomerang drug pricing order bark little bite",
    "text": "pharmaceutical boomerang monday trump sign executive order tie drug u.s international tag"
  },
  {
    "headline": "histosonic secure first insurance coverage histotripsy system",
    "text": "michigan first us state offer reimbursement histonic fda approve edison histotripsy system"
  },
  {
    "headline": "trump expect sign order slash drug",
    "text": "president trump expect sign executive order intend cut prescription drug order match drug overseas yahoo senior health reporter anjalee khemlani outline many step government agency involve investigate carry act watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "mag 7 rally airline pharmaceutical trend ticker",
    "text": "magnificent seven make nvidia nvda alphabet goog googl tesla tsla microsoft msft amazon amzn meta meta apple aapl rally us china agree lower tariff 90 day period airline like american airlines aal delta dal united airlines ual also gain trade deal pharmacy include eli lilly lly johnson johnson jnj merck mrk move downside us president trump say cut drug 50 watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "us china trade truce april cpi drug 3 thing",
    "text": "us future es f nq f ym f surge monday morning china official agree significant cut country respective tariff 90 day cool period april consumer cpi due tomorrow report month month trend inflation president trump vow cut prescription drug much 80 turn pharmaceutical see across board pullback pre watch expert insight analysis late action check morning brief nbsp"
  },
  {
    "headline": "pharma fall pre bell follow plan trump reduce prescription drug",
    "text": "pfizer pfe astrazeneca azn johnson johnson jnj drug company fall mond"
  },
  {
    "headline": "j j report new datum phase iii trial icotrokinra plaque psoriasis",
    "text": "primary endpoint meet 57 subject treat therapy achieve clear almost clear skin"
  },
  {
    "headline": "johnson johnson jnj good income invest",
    "text": "recently publish list good income invest article go take look johnson johnson nyse jnj stand good income amid concern trade restriction weakening economy seek stability dividend pay traditional defensive"
  },
  {
    "headline": "johnson johnson nyse jnj announce positive trial result amid legal setback",
    "text": "johnson johnson nyse jnj recently announce promising phase 3 result icotrokinra new investigational treatment psoriasis face legal challenge jury award $ 3 million verdict link baby powder use development coincide 3.77 rise company past month movement reflect broad trend dow jones relatively flat amid ongoing u.s.-china tariff discussion johnson johnson positive"
  },
  {
    "headline": "j j oral psoriasis drug help patient achieve clear skin late stage study",
    "text": "drugmaker work convenient treatment option injectable psoriasis drug stelara gain $ 10 billion sale last year face stiff competition cheap rival j j say last month expect drug icotrokinra generate sale $ 700 million 2028 btig analyst julian harrison expect icotrokinra complement rather disrupt leader include j j tremfya abbvie skyrizi"
  },
  {
    "headline": "icotrokinra result show significant skin clearance patient difficult treat scalp genital psoriasis",
    "text": "johnson johnson nyse jnj today announce new datum phase 3 iconic totala study investigate icotrokinra jnj-2113 first class investigational target oral peptide selectively block il-23 receptor study evaluate adult adolescent 12 year age old body surface area low 1 least moderate plaque psoriasis pso affect high impact skin site"
  },
  {
    "headline": "johnson johnson jnj good medical device buy",
    "text": "recently publish list 11 good medical device buy article go take look johnson johnson nyse jnj stand good medical device buy trump tariff divide medical community april 16 cnbc report trump tariff"
  },
  {
    "headline": "zymeworks inc zyme q1 2025 earning call highlight revenue surge strategic partnership",
    "text": "zymeworks inc zyme report significant revenue increase strong cash position navigate rise expense strategic uncertainty"
  }
]